Dova Health Intelligence will be attending ECCO Congress 2026, a leading international conference focused on advances in inflammatory bowel disease (IBD) research and care. The congress brings together clinicians, researchers, and industry leaders from around the world to explore the future of IBD treatment and innovation.

‍

Representing Dova at ECCO 2026 will be Solveig Johannessen, Chief Executive Officer, and Dr. Michael Byrne, Founder and Chairman. They’ll be onsite to connect with members of the global IBD community and discuss how data-driven, AI-powered tools can support better clinical decision-making.

‍

If you’re attending ECCO 2026, we’d be glad to connect—reach out to schedule a conversation with our team.

‍